Chapter 13: Diuretic Drugs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

I am so glad you are here with us today.

We are doing something a little bit distinct from our usual programming.

A little bit of a turn.

Yeah, a sharp turn actually.

Usually we are bouncing around between, you know, history, tech, sociology, maybe a bit of pop culture analysis.

But today, today we are catering to a very specific, and I'm guessing very stressed out segment of our audience.

You know exactly who you are.

The panic is palpable.

I can feel it.

It is.

Maybe you're a medical student with step one leaning over your head like a dark, thunderous cloud.

Maybe you're a nursing student trying to make sense of your pharmacology notes, which right now probably look like hieroglyphics.

Or maybe you're a resident doing rounds and you just realize you can't quite articulate the difference between Lasix and hydrochlorothiazide when the attending physician turns to you and asks.

The dreaded pimping questions on rounds.

We have all been there.

It is a rite of passage, but it doesn't have to be painful.

Exactly.

So we are teaming up with the Last Minute Lecture mindset today.

We have a stack of notes.

We have the text specifically chapter 13 of Brenner and Stevens Pharmacology, sixth edition.

And we are going to tackle a beast of a topic.

We are doing a deep dive into diuretic drugs.

And this is such a foundational chapter.

Honestly, you cannot practice medicine, especially internal medicine, cardiology, nephrology, without mastering diuretics.

They are the absolute bread and butter of managing fluid balance in the human body.

And our mission today is pretty simple.

We are going to demystify this.

We're going to translate that dense, often dry textbook language into a clear college level audio guide.

We're going to walk you through the nephron anatomy, the specific drug classes, the mechanisms of action, and crucially, the side effects.

And the side effects are really the key here.

With some drug classes you just have to memorize this sort of random list of bad things that can happen.

But with diuretics, the side effects are directly predicted by understanding the physiology.

If you know how the kidney works, you can predict toxicity.

It is not memorization.

It is logic.

I love logic.

Logic is so much easier to remember than a random list.

So before we get into the molecular weeds, and believe me, we will get into the weeds, let's zoom out.

What is the big picture here?

Why are these drugs so important in the clinical setting?

Well, fundamentally, diuretics are about volume control.

The human body is mostly water.

And keeping that water in the right compartments is a full -time job for the kidneys.

When that system fails, we get edema.

Edema.

Which, in layman's terms, is just swelling.

It is swelling, but clinically, it's fluid accumulation in the interstitial spaces or, you know, body cavities.

And this happens in major system failures.

Think about heart failure, where the pump is just too weak to move fluid forward so it backs up.

Right, like a plumbing backup.

Exactly.

Or think about kidney disease, where the filter itself is broken.

Or liver cirrhosis, where you stop making the proteins that hold water inside the blood vessels.

The body holds on to too much salt and water, and we need to help the kidneys get rid of it.

And it's not just edema, right?

The text lists hypertension, high blood pressure, as a primary indication.

Absolutely.

In fact, phyasdide diuretics are often the very first drug we prescribe for high blood pressure.

It's a physics problem, really.

If you reduce the fluid volume inside the pipes, your blood vessels, the pressure against the walls goes down.

It's plumbing 101.

It really is.

We also use them for glaucoma, to lower pressure in the eye, and for some specific electrolyte disorders.

But to really understand the goal, we have to define our terms.

You're going to hear the word uresis a lot in this hour.

Right.

Let's clean up the vocabulary before we start.

The chapter lists three big terms that end in uresis.

First, obviously, diuresis.

Simple enough.

Diuresis is just an increase in urine production.

If the volume of your urine goes up, that is diuresis.

If you drink a gallon of water and then pee a lot, that's a water diuresis.

It's all about the output volume.

Okay.

Term number two, and this one feels like the really important one based on the reading.

Natriuresis.

This is the key.

Natriuresis is the excretion of sodium in the urine.

And this is the golden rule of diuretics, the one thing you absolutely must tattoo on your brain.

Water follows sodium.

Because of osmosis.

Exactly.

Sodium is an osmotically active particle.

It acts like a little magnet for water.

So the kidney filters tons of water and salt every day.

It then tries to reabsorb most of that salt back into the blood.

And water naturally wants to follow that salt back into the blood.

So the diuretics stop that.

Right.

Most diuretics work by preventing the kidney from reabsorbing sodium.

If the sodium stays in the urine, the water stays in the urine with it, and you get

So natriuresis drives diuresis.

Precisely.

You block the salt, you move the water.

It's that simple at its core.

And then the third term, which kind of sounds like the villain of the story,

caliuresis.

Yes.

Caliuresis is the excretion of potassium in the urine.

Cali comes from calium, the Latin name for potassium, which is why its symbol is K on the periodic table.

Okay.

So why is this the villain?

Because while we usually want natriuresis to get rid of fluid, caliuresis is often an unintended and sometimes dangerous consequence.

The body's machinery for handling sodium is inextricably linked to potassium.

They're tied together.

They're tied together.

Often, to get rid of one, you end up losing the other.

And losing too much potassium, a condition called hypokalemia, can be very dangerous.

It causes muscle weakness and more importantly, fatal cardiac arrhythmias.

Wow.

So balancing the good sodium loss with the bad potassium loss is really the art of using these drugs safely.

Okay.

So we have the vocabulary.

Diuresis is water, naturesis is sodium, caliuresis is potassium.

Now let's look at the roadmap for today.

The text organizes this discussion geographically.

We're going to follow the path of the filtrate through the nephron.

This is the best way to learn it.

I always tell my students, don't just memorize drug names in alphabetical order.

That is a recipe for disaster on an exam.

You have to visualize the kidney as an assembly line or maybe more like a disassembly line.

We start at the beginning and we move to the end.

So we'll look at the proximal tubule, then the loop of Henle, the distal tubule, and finally the collecting duct.

And at each stop, we will see a different class of drugs that targets the specific machinery of that section.

It's like a guided tour of a factory where we go around and break different machines just to see what happens.

All right.

Let's start the tour.

Section one, nephron function and sites of drug action.

Let's set the scene.

So the functional unit of the kidney is the nephron.

And its main job is to filter the blood and then selectively decide what to keep and what to throw away.

Sodium and other electrolytes are reabsorbed from the nephron back into circulation.

But this isn't magic.

It happens via very specific active and passive processes.

The text mentions ion channels and transport protein.

Can we just quickly clarify the difference there for everyone listening?

Yeah, that's a great point.

They're not the same.

You can think of an ion channel like an open door or a tunnel.

It lets specific ions flow down their gradient like water flowing downhill.

It's passive diffusion, but it's selective.

Only the right key fits the lock, so to speak.

And transporters are different.

Transporters are more like machines with moving parts.

You have symporters, which act kind of like a carpool lane.

They grab two or more ions, say sodium and chloride, and move them in the same direction across the membrane.

Okay.

Then you have antiporters, which act like a revolving door at a hotel.

One person enters and another person has to leave.

So one ion moves into the cell and a different ion moves out.

Empowering all of this machinery is the sodium pump, right?

The Ni plus K plus At pace.

Correct.

That pump is the engine.

It is constantly burning energy ATP to pump sodium out of the kidney cell and potassium in.

This is so important because it keeps the sodium concentration inside the kidney cells very, very low.

And why does that matter so much?

Because it creates a vacuum.

Since sodium is so low inside the cell, sodium from the urine wants to rush in.

That gradient, that powerful desire for sodium to enter the cell, is the battery that powers all the other symporters and antiporters we're going to talk about.

If you stop the sodium pump, everything just stops.

The text refers to box 13 .1, which has this great diagram of the sites.

Let's try to visualize it together.

The journey starts at the glomerulus.

Glomerular filtration.

Right.

This is where the blood enters these tiny little capillaries in the kidney.

The pressure is super high and it forces fluid out of the blood and into the nephron tube.

We call this the ultrafiltrate.

It's basically blood plasma minus the big proteins in red blood cells.

Now, there's a really important distinction to make right off the bat here.

The diuretic drugs we are discussing in this chapter do not increase the glomerular filtration rate or GFR.

That is a critical point.

I think when I first learned this, I always assumed if we were making more urine, we must be filtering more blood, but that's actually false.

It's a very common misconception.

These drugs act downstream.

They work on reabsorption.

They don't make the filter work any faster.

In fact, if a diuretic works too well and you get dehydrated, your blood volume drops and your GFR might actually decrease.

Right.

And you know, there are some drugs like digitalis, a cardiac stimulant, that can increase GFR indirectly by making the heart pump stronger, which sends more blood to the kidney.

But they aren't diuretics in the pharmacological sense.

The drugs we are studying today are saboteurs.

Saboteurs, I like that.

They wait for the fluid to be filtered, and then they stop the kidney from taking it back.

Got it.

So the factory line starts running at the glomerulus, but our agents are waiting further down the line.

The first stop after the glomerulus is site A, the proximal tubule.

The proximal tubule is the heavy lifter.

It's the first segment, and it's responsible for reabsorbing essentially all the filtered glucose, amino acids, and other organic solutes.

This is why if you find sugar in your urine, it means your proximal tubule is overwhelmed, which is what happens in diabetes.

How much sodium does it handle?

It reabsorbs a huge amount, about 65 % of the sodium in water.

But crucially for our discussion, it reabsorbs about 85 % of the filtered sodium bicarbonate.

85%.

That seems massive.

It is.

This reabsorption of bicarbonate relies on a specific enzyme called carbonic anhydrase.

And this is our first drug target.

We have a whole class of diuretics called carbonic anhydrase inhibitors that work right here at this first stop.

We will definitely cover those in detail later, but the text makes a point of saying they are actually weak diuretics.

Why is that?

If they block the very first and biggest step, shouldn't they be the strongest?

You would think so, wouldn't you?

But the kidney is smart.

It has redundancy.

Even if you block reabsorption in the proximal tubule, the rest of the nephron, the loop, and the distal tubule can compensate.

They see all that extra fluid coming down the pipe, and they basically say, whoa, look at all this salt.

We better work harder.

And they just pick up the slack.

So the net loss of fluid is actually pretty small by the end.

Exactly.

The downstream segments buffer the effect.

There's one other thing happening in the proximal tubule that is crucial for pharmacology, isn't it?

Secretion.

Yes, this is vital.

The proximal tubule doesn't just reabsorb things.

It has secretory systems for organic acids and bases.

It actively pumps things into the urine from the blood.

This is how your body gets rid of waste products like uric acid.

But it also pumps drugs.

Exactly.

Most of the diuretics we're going to talk about, like thiazides and loop diuretics, are large molecules that are bound to proteins in the blood.

Because of that, they can't filter through the glomerulus very well.

So they have to be actively transported into the nephron.

Right, by these secretory pumps in the proximal tubule.

This is their only way in.

So for a diuretic to work, it has to catch a ride into the nephron right here at the beginning.

Correct.

And this has clinical implications.

If your proximal tubule function is compromised, say in some types of kidney disease, or if another drug is competing for that same pump, the diuretic might never reach its site of action.

It's like sending a saboteur into the factory.

If he gets stuck at the security gate, the proximal tubule, he can't go sabotage the machine further down the line.

That makes perfect sense.

Okay, moving on.

We leave the proximal tubule and head down into the abyss site B.

The loop of Henlo, specifically the thick ascending limb.

This is a really critical site.

The loop of Henlo dips deep into the kidney's medulla.

And its job is to reabsorb salt to create a very salty environment in the surrounding tissue.

It reabsorbs about 35 % of filtered sodium chloride.

35%.

Still a huge chunk.

And what's the machine here?

What's the target?

The transporter here is famous.

It is the NaN plus K plus 2Cl symporter.

That is a mouthful.

Sodium, potassium, two chloride symporter.

It moves one sodium, one potassium, and two chloride ions out of the urine and into the cell.

This process is absolutely vital because it pumps all that salt into the surrounding tissue.

The interstitium making it hypertonic.

Hypertonic just means super salty, right?

Yes, very, very salty.

That salty environment is what allows the kidney to concentrate urine later on.

It creates the osmotic gradient to pull water out of the collecting duct.

So if you break this mechanism, you lose the ability to make concentrated urine.

And this is where the loop diuretics act.

This is their home.

By blocking that symporter, they stop a massive amount of salt reabsorption.

And because this site handles 35 % of the salt, blocking it causes a profound diuresis.

These are the heavy artillery of the diuretic world.

Okay, but there's a side effect mechanism here we need to flag.

It involves calcium.

Yes, this is a key distinction.

Walk me through this.

How does blocking sodium and chloride affect calcium?

They aren't even in the transporter's name.

It's all about electricity.

It's a bit indirect.

So normally the symporter brings in sodium, chloride, and potassium.

But potassium is a little tricky.

It has a tendency to leak back out of the cell into the urine through specific potassium channels.

Okay, so it gets pulled in and then just leaks back out.

Exactly.

And this back diffusion of potassium, which is a positive ion, creates a positive electrical potential in the lumen of the nephron.

The urine itself becomes slightly positively charged.

So the inside of the tube is positive.

A little bit.

Yeah.

But that positive charge repels other positive ions, specifically calcium, Ca2 +, and magnesium, Mg2+.

It literally pushes them away from the urine between the cells and back into the blood.

It's a paracellular pathway.

Wow.

So normally the electricity from the leaking potassium is what pushes the calcium back into the blood.

Precisely.

But now imagine you use a loop diuretic.

You stop the symporter.

No more sodium, potassium, or chloride comes in.

Which means no more potassium can leak back out.

Right.

And if no potassium leaks out, you lose that positive electrical potential.

And without the positive charge?

The pushing force is gone.

The calcium and magnesium are no longer repelled.

They just stay in the urine and get flushed out.

Okay.

I am definitely underlining that.

Loop diuretics cause calcium loss.

I have a feeling that is going to be very important for comparison later.

It absolutely will be.

Let's move on to site C, the distal tubule.

We're getting further down the line.

What happens here?

By the time we reach the early distal tubule, a lot of the salt has already been reclaimed.

This segment is less of a heavy lifter.

It only reabsorbs about 5 % to 10 % of the filtered sodium chloride.

So much less than the loop.

Right.

And the transporter here is simpler too.

It's a Na plus, a Cl symporter.

Just sodium and chloride, no potassium involved.

This is the target site for the thiazide diuretics.

And because they're blocking a smaller percentage of the total sodium reabsorption, that would make them less potent than the loop diuretics.

Generally, yes.

They produce a more moderate diuresis.

Okay.

And finally, we reach the end of the line, site D, the collecting duct.

The collecting duct is the final adjustment station.

It decides the final volume and composition of the urine to maintain total body homeostasis.

It only reabsorbs about 3 % of the filtered sodium.

But this 3 % is critical for fine tuning.

And this is where the hormones come into play, right?

I remember this from physiology.

Correct.

This is the primary site of action for aldosterone and antidiuretic hormone, ADH.

Aldosterone tells the kidney to keep sodium, which brings water with it.

Well, ADH tells the kidney to keep just water by inserting special water channels.

And there's an exchange happening here with the sodium.

Yes.

This is crucial for understanding potassium loss from other diuretics.

In the collecting duct, sodium doesn't just enter the cell for free.

It enters through a channel.

And to keep the electrical charge inside the cell balanced, the cell has to secrete something positive back out into the urine.

Then it usually secretes.

It usually secretes potassium, K +, or hydrogen, H+.

So you can think of it as a trait.

The body takes a sodium ion from the urine and, in return, gives up a potassium ion.

Exactly.

So now imagine a huge amount of sodium arrives at the collecting duct.

Because we blocked its reabsorption upstream with the thiazide or looped diuretic.

The collecting duct goes into overdrive.

It starts grabbing all that sodium.

But to do so, it has to dump massive amounts of potassium into the urine.

That explains it perfectly.

That's why upstream diuretics cause downstream potassium loss.

Perfectly put.

And that is also why drugs that act here at the collecting duct itself are called potassium -sparing diuretics.

They stop that trait from happening so you don't lose the potassium.

The map is set.

We have our four sites.

Proximal, loop, distal, and collecting duct.

Now let's go back and unpack the specific drugs that hit these targets.

Starting with the most commonly used class.

Section 2, thiazide and related diuretics.

Yes.

The thiazines are the workhorses.

They're orally active.

They're effective for most uncomplicated cases of hypertension and edema.

And they're generally well tolerated.

If you go to a primary care doctor with mild high blood pressure, there's a very good chance you're leaving with a script for a thiazide.

And the text mentions hydrochlorothiazide is the big name here.

Yes.

Hydrochlorothiazide, often just abbreviated HCTZ, is the most prescribed.

But they're also thiazide -like diuretics.

Drugs like chlorthalidone, endopamide, and metolazone.

They look a little different chemically, but they do the exact same thing at the exact same site.

And structurally, these are sulfonamides.

That sounds familiar.

They are.

They contain a sulfur component.

And that's an important note for patients with a listed sulf allergy.

Though, strictly speaking, the data shows that cross -reactivity between antibiotic sulf allergies and non -antibiotic sulfonamides, like thiazides, is actually pretty rare.

Still, it's a box we tick on the chart.

OK.

Let's talk mechanism.

We know they block the Ni plus of ales supporter in the distal tubule.

But let's look at figure 13 .1 in the text.

It's this great diagram that highlights a domino effect of adverse effects.

Yeah.

It's a fantastic visual.

It's not just a random list of side effects.

It's a chain reaction.

Because they mess with the core electrolytes, they trigger a whole cascade of metabolic issues.

Let's start with the potassium.

We already established that thiazides cause calyuresis potassium loss.

Right.

It's that downstream effect.

They block sodium in the distal tubule, so more sodium flows to the collecting duct.

The collecting duct sees all that sodium and starts trading it for potassium.

Potassium goes down the drain.

This leads to hypokalemia.

And hypokalemia then triggers another problem, metabolic alkalosis.

How does that happen?

This is a bit complex, but stick with me.

When your blood is low on potassium, your body cells try to help out.

They release their own internal stores of potassium into the blood to buffer the level.

But to keep their own electrical charge balanced, they have to take in something positive from the blood.

And they take in hydrogen ions.

Exactly.

They take an H plus already.

So hydrogen goes into the cells and out of the blood.

And less hydrogen in the blood means a higher pH.

That is alkalosis.

On top of that, in the collecting duct, if there isn't enough potassium available to trade for sodium, the kidney starts trading hydrogen ions instead.

So you literally pee out acid, making the blood even more alkaline.

Okay.

So that's the electrolyte chaos.

What about the other side effects?

The text mentions gout.

Hyperuricemia.

Yes.

Remember way back when we said the diuretics have to be secreted into the proximal tubule to work?

Right.

They compete for that door?

Well, uric acid is also secreted there.

It turns out they compete for the exact same transport door.

So if the door is busy moving the thiazide molecule into the urine, the uric acid has to wait in line.

It builds up the blood.

And for patients who are susceptible, that high uric acid can crystallize in their joints, triggering a painful gout attack.

Ouch.

And blood sugar.

That was a surprising one.

Hyperglycemia.

This one is linked back to the low potassium.

It turns out that the beta cells in the pancreas need a normal level of potassium to secrete insulin properly.

So if you're hypokalemic, insulin secretion drops, and your blood sugar can rise, it can actually be enough to tip a pre -diabetic patient into full -blown diabetes.

That is a really serious consideration.

And lipids, too.

Yes.

They can elevate cholesterol and LDL levels.

The mechanism is a bit more complex, There's some debate about how clinically significant it is in the long run, but it's something we monitor.

Now here is the one that really stood out to me as a major distinction, the one we flagged earlier.

We said loop diuretics make you lose calcium, but thiazides make you keep calcium.

Yes, this is a huge point.

Thiazides decrease calcium excretion.

They cause hyperkalcemia, or at least a tendency towards it.

Why?

What's the mechanism?

It's a completely different mechanism than what we saw in the loop.

It has nothing to do with the electrical potential.

Chronic use of thiazides actually changes the gene expression of calcium transport proteins in the distal tudial cell.

Specifically, a channel called TRPV5 and a binding protein called calbindin.

It essentially upgrades the cell's ability to reclaim calcium from the urine.

So if I'm thinking about a clinical application, if I have a patient who keeps getting painful kidney stones, and those stones are made of calcium.

Thiazides are a fantastic treatment for that.

By pulling that excess calcium out of the urine and back into the blood, you prevent the stones from forming in the first place.

This is a classic indication treating nephrolithiasis.

It's perfect two birds with one stone scenario if the patient has both high blood pressure and a history of calcium kidney stones.

Okay, so let's summarize the indications for thiazides.

Hypertension is the primary one.

Edema in mild to moderate heart failure.

Kidney stones.

But then there's this really weird one listed.

Diabetes insipidus.

Ah, the paradox.

This is a favorite exam question for a reason.

Yeah, please explain this to me.

Diabetes insipidus is a condition where you pee way too much like 10 to 20 liters a day because your antidiuretic hormone, ADH, is not working.

You are losing massive amounts of water.

Why on earth would we give a diuretic a drug that makes you pee to someone who is already peeing too much?

It sounds totally backwards, doesn't it?

It feels like giving a laxative to someone who has diarrhea.

But here is the very clever logic.

In diabetes insipidus, the patient is losing massive amounts of very dilute water.

When you give a thiazide, you cause a mild natriuresis, which leads to a slight reduction in their total plasma volume.

You dehydrate them just a tiny bit.

Okay, I'm with you so far.

That small drop in volume triggers a reflex.

The body's volume sensors detect it and send a signal to the proximal tubule.

The kidney thinks, oh no, we're drying out.

We need to conserve everything.

So the proximal tubule starts sucking up as much salt and water as it possibly can, very early in the nephron.

So you're basically starving the faulty downstream segment of fluid to work with?

Exactly.

You are dramatically reducing the delivery of fluid to the end of the nephron, where the problem actually is.

The net result is actually a significant decrease in total urine volume, sometimes by as much as 50%.

You are tricking the proximal part of the kidney into working overtime to save water.

That is fascinating.

It's a physiological bank shot.

It's pharmacology jiu -jitsu, using the body's own compensatory mechanisms against itself to get the effect you want.

All right, let's shift gears to the heavy hitters.

Section three, loop diuretics.

Yes, these are the high ceiling diuretics.

Why high ceiling?

What does that mean?

The text shows a graph comparing the dose -response curves.

It's figure 13 .2.

With psilocides, the curve is relatively flat.

Once you reach a certain dose, giving more of the drug doesn't make you pee anymore.

You hit a low ceiling, the transporter is fully saturated.

But the curve for the loops is different.

Oh yeah, loops have a steep continuous curve.

The more you give, the more diuresis you get, almost without limit until you dehydrate the patient entirely.

That is why these are used in emergencies.

If you have a patient who is drowning in their own fluid -like and acute pulmonary edema, you do not want a ceiling.

You want maximum power.

The key drugs here are furosemide brand name,

lasixbumetanide, and torsemide.

And then there's one oddball, ethicrinic acid.

Right.

Ethicrinic acid is unique because it is the only loop diuretic that is not a sulfonamide.

So if you have that rare patient with a severe, life -threatening sulfo allergy, I'm talking true anaphylaxis, not just a rash.

This is your alternative.

It's rarely used otherwise because it's a bit harder to manage and has more side effects.

But it is a lifesaver in that very specific niche.

And the mechanism of action.

We covered this in our geography tour.

They inhibit the Na plus K plus 2 Cl symporter in the thick ascending limb of the loop of Henle.

And as we noted, by stopping that pump, you destroy the electrical potential, so you lose calcium and magnesium along with the sodium.

Correct.

So while thiazitis can cause hypercalcemia, high calcium,

loops called hypercalcemia, low calcium, and also hypomagnesemia.

We actually use this effect clinically.

If a patient has dangerously high calcium levels, say from a malignancy,

we can give them IV saline and high doses of loop diuretics to literally flush the calcium out of their body.

Now there is a specific warning box in the chapter for loop diuretics regarding side effects.

Something about the ears.

Autotoxicity.

Yes, this is a serious one and very specific to this class.

High doses of loop diuretics can cause tinnitus, bringing in the ears, vertigo, and even transient or permanent hearing loss.

How does that happen?

It turns out the inner ear, specifically the stria vascularis, uses a very similar ion transport system to the kidney to maintain the proper chemical composition of the endolent fluid that's critical for hearing.

Loops disrupt that delicate balance in the ear, just like they do in the kidney.

Is it permanent?

It's usually reversible if you stop the drug, but not always.

It's definitely dose dependent.

It happens more often if you push the dose too high, too fast, especially intravenously.

And ethicrinic acid, that non -sulfid drug we mentioned, is actually the worst offender for ototoxicity.

That's really good to know.

What about the kidneys themselves?

The text makes a really important distinction about their use in renal impairment.

This is a crucial clinical rule to memorize.

Thiazides generally stop working if the patient's kidney function gets too poor.

Specifically, if their creatinine clearance drops below 30 melamellums, thiazides lose their efficacy.

They just can't get secreted into the tubule effectively enough to work.

But loops are different.

Loops keep working.

Even in patients with severe renal impairment, high doses of furosemide can still squeeze out urine.

That is why loop diuretics are the drug of choice for managing fluid overload in patients with chronic kidney disease or renal failure.

So to recap loops, they are incredibly potent.

They work even when the kidneys are failing.

They make you dump calcium, and they can hurt your ears.

And just like thiazides, they also cause hypokalemia, low potassium, and metabolic alkalosis via that same downstream mechanism in the collecting duct.

They deliver a tidal wave of sodium there.

Which brings us perfectly to the solution for that very problem.

Section 4.

Potassium sparing diuretics.

The name says it all.

The primary goal here isn't usually massive diuresis.

In fact, on their own, these are very weak diuretics.

Their main job is to counteract the potassium loss caused by the other drugs.

They're the sidekicks.

The text divides these into two subclasses based on their mechanism.

Let's start with the first one.

Epithelial sodium channel blockers.

The drugs are amylaride and triamtrane.

These work right in the collecting duct.

So remember, we said sodium enters the cell through a special channel.

And in exchange, potassium gets kicked out.

Amylaride and triamtrane just physically block that sodium channel.

Like putting a cork in it.

Exactly.

It's a purely physical block.

If sodium cannot come in, the electrical gradient that drives potassium secretion never develops.

And the cell has no incentive to kick potassium out.

The exchanges stop cold.

You lose a little bit of salt, which gives you a mild diuresis.

But you save the potassium.

A very simple, direct mechanism.

Now, the second class is a bit more complex.

Aldosterone antagonists.

The big ones are spironolactone and aplerinone.

These are arguably more important clinically, especially in heart failure.

Spironolactone is a structural analog of the hormone aldosterone.

Looks just like it to the body.

So it acts as a competitive inhibitor for the receptor.

Precisely.

It sits in the mineralocorticoids receptor and blocks aldosterone from binding.

But here's the key thing to understand about how aldosterone works.

It's a steroid hormone.

It works by going into the nucleus of the cell and actually changing gene expression.

It tells the cell's DNA, hey, make more sodium pumps.

Make more sodium channels.

So aldosterone is a builder.

It constructs the machinery for sodium retention.

Right.

So when you block it with spironolactone, you are preventing the construction of that machinery.

But because this involves turning genes on and off and in protein synthesis, it takes time.

The text mentions a significant delay in the onset of action.

Yes.

A loop diuretic given IV worked in minutes.

Spironolactone can take days, sometimes two to three days, to reach its full effect because you have to wait for the existing pumps and channels to naturally degrade and for the no new pumps order to take full effect.

That is a key deep dive detail.

Do not expect instant results with spironolactone.

Now, spironolactone has a notorious side effect profile because it's kind of a dirty drug, right?

It is.

Because it looks so much like a steroid hormone, it doesn't just hit the mineralocorticoid receptor.

It also has significant antiandrogenic effects.

It blocks testosterone receptors.

Which leads to what, clinically?

In men, it can cause gynecomastia, which is painful breast tissue growth and impotence.

In women, this effect can actually be used therapeutically.

We use it to treat conditions like polycystic ovary syndrome, PCOS, to help with hirsutism, which is excess hair growth, because it blocks the effects of androgens.

But if you're a male heart failure patient who needs this drug for its cardiac benefits, that side effect is not ideal at all.

Not at all.

Which is why we now have a plarinet.

It's a newer drug, it's cleaner, and it's much more selective for the aldosterone receptor.

It has far fewer of those endocrine side effects.

The downside is it's more expensive, but it spares the patient the hormonal issues.

Now, the obvious danger with all of these potassium sparing drugs is the opposite of the others.

Instead of hypokalemia, we risk hyperkalemia, too much potassium.

Which can be just as, if not more, fatal.

High potassium is very dangerous for the heart, it can cause fatal arrhythmias.

This is especially risky if you combine these diuretics with other drugs that also raise potassium, like ACE inhibitors, drugs ending in Ibril, or ARBs.

Or if the patient is taking potassium supplements without realizing the danger.

You have to monitor the labs very, very closely.

The text actually mentions a newer drug here, not a diuretic, but a fixer for this exact problem.

Petrimer Veltasa.

Yes, this has been a game changer for managing heart failure patients.

Often, we really want to keep a patient on spironolactone or an ACE inhibitor, because those drugs are proven to save lives.

But their potassium level starts to creep up too high.

Petrimer is a binding agent you take orally.

It binds potassium in the GI tract, so you just poop it out, which lowers the blood levels.

So it allows you to keep the patient on the beneficial heart drugs without the potassium risk?

Exactly.

It's a workaround for a very common and dangerous side effect.

Okay.

Let's move to the real specialty tools in the box.

Section 5, osmotic diuretics.

The main ones are mannitol and glycerol.

These work on pure physics, not chemistry.

Explain that.

What do you mean?

Well, most drugs we've talked about bind to a receptor or an enzyme to have their effect.

Mannitol is just a sugar alcohol.

When you inject it intravenously, it gets freely filtered at the glomerulus into the nephron.

But the tubules cannot reabsorb it.

It's stuck in the tube.

And because it stays there.

It exerts osmotic pressure.

It literally holds onto water molecules, refusing to let them be reabsorbed out of the nephron.

It's like putting a super dry sponge in the tubule that just soaks up water and keeps it there.

But it also acts before it even gets to the kidney, right?

Yes.

This is a critical part of its mechanism.

When mannitol is in the blood, before it's excreted, it's a powerful osmotic agent in the bloodstream itself.

It sucks water out of the body cells and tissues and pulls it into the blood plasma.

So where do we use this?

Not for blood pressure, surely?

No, absolutely not.

We use this for cerebral edema.

If someone has swelling in their brain from trauma or a stroke, you have to remember the skull is a closed box.

That swelling can be fatal.

Mannitol sucks the excess water out of the brain tissue and into the blood where the kidneys can then pee it out.

It reduces intracranial pressure.

And the text also mentions acute glaucoma.

Same exact principle.

It pulls fluid out of the eyeball to lower the pressure, usually in an emergency or right before surgery.

But there is a very big danger here, if it sucks a lot of water into the blood.

You get a rapid plasma volume expansion.

Before the kidney has a chance to pee it all out, your blood volume can spike dangerously.

If a patient has a weak heart, this sudden flood of fluid into their veins can trigger acute heart failure or flash pulmonary edema.

You have to be incredibly careful.

You can literally drown the patient's lungs while you're trying to dry out their brain.

A very fine line to walk.

Next up, section six, carbonic anhydrase inhibitors.

The main one is acetazolamide.

We touched on this at the very beginning at the proximal tubule.

Right.

They inhibit the enzyme, carbonic anhydrase, that's needed to reabsorb bicarbonate.

The net result is that you pee out a ton of sodium bicarbonate.

And since bicarbonate is a base, your urine becomes alkaline and your blood becomes acidic.

You get a metabolic acidosis.

And as we said, the text calls them weak diuretics for fluid volume, but they have some very interesting niche uses.

Glaucoma is a big one.

The eye needs carbonic anhydrase to make the aqueous humor fluid, so blocking it lowers eye pressure.

But the really fascinating one is high -altitude sickness.

How does that work?

This is one of those physiology puzzles I love.

Okay, picture this.

You go to climb Mount Everest.

The oxygen in the air is low.

To get more oxygen, you naturally start breathing faster.

You hyperventilate.

Right.

Makes sense.

But breathing fast blows off a lot of CO2.

And CO2 is acidic in the blood.

When you lose it, your blood becomes alkaline, a condition called respiratory alkalosis.

And the brain doesn't like that.

The brain's respiratory drive center in the brain stem monitors pH to decide how much to breathe.

If the blood is too alkaline, the brain says, whoa, we do not need to breathe this much.

And it actively slows down your breathing rate.

But you need to breathe because of the low oxygen.

It's a paradox.

Exactly.

It is a dangerous conflict.

The pH signal is fighting the low oxygen signal.

So your brain makes you stop breathing as much, you become more hypoxic, and you get mountain sickness.

So the drug fixes the pH problem?

Yes.

Acetazolamide forces the kidneys to dump bicarbonate, which creates a mild metabolic acidosis.

This acidosis cancels out the respiratory alkalosis from the hyperventilation.

It returns the blood pH to normal.

This essentially resets the drive to breathe, allowing you to keep hyperventilating to get the oxygen you need, especially while you're trying to sleep at high altitude.

That is some truly elegant physiology.

It's basically biohacking.

It really is.

It's a beautiful example of applied physiology.

Finally, let's talk about the new kids on the block.

Section seven, antidiuretic hormone antagonists.

The Vaptins, Conovaptin, and Tolveptin.

These are often called aquaeretics because they excrete only water.

They cause a pure water diuresis, not a salt diuresis.

That's a mechanism.

They block the V2 receptors in the collecting duct.

Normally, ADH or vasopressin hits these receptors and tells the cell to insert water channels, called aquaporins, into its membrane.

These drugs block that signal.

The aquaporin channels stay inside the cell, the membrane remains impermeable to water, and free water just flows right out into the urine.

And this is used for hyponatremia low blood sodium.

Specifically, uvolymic or hypervolymic hyponatremia.

So imagine a patient whose blood is too dilute.

They have plenty of salt, but it's just watered down by too much fluid.

These drugs allow you to flush out only the excess water, concentrating the remaining salt back to a normal level.

There's a case study, box 13 .2 in the text, about this exact situation.

A 58 -year -old woman with lethargy and confusion, she had SIADH, or syndrome of inappropriate ADH secretion.

Right.

Her body was making way too much ADH, so she was holding on to too much free water.

Her sodium dropped to 118.

Normal is around 135 -145.

A level of 118 is dangerously low.

That confusion she was having is a classic sign of brain swelling from the low sodium.

They tried fluid restriction first, but it didn't work for her.

It's very hard to stick to.

Imagine being told you cannot drink water when you are thirsty.

And often, it's just not effective enough against a strong ADH signal.

So they gave her tolveptin.

The text says it caused profound diuresis.

Her sodium rose to 130, and her mental status completely cleared up.

But the text gives a very strong warning.

Do not correct the sodium too fast.

This is absolutely critical.

If you strip the water away from the body too quickly, the brain cells, which have swollen up to adapt to the low sodium environment, can shrink down too rapidly.

This causes a devastating neurological condition called osmotic demyelination syndrome.

It damages the myelin sheath of the neurons and can cause permanent paralysis and brain damage.

So when you use a drug like tolveptin, you are checking the patient's sodium levels every few hours.

You have to go slow and steady.

We have now covered the entire nephron from start to finish.

Let's bring it all home with section 8, management of edema.

Why are we doing all of this?

It all comes back to managing the forces of starling from basic physiology.

Edema comes from either too much hydrostatic pressure -like and heart failure, where the weak pump is pushing fluid out of the capillaries, or too little oncotic pressure, like in liver failure, where you can't make the albumin protein needed to hold fluid in.

And the strategy we use depends entirely on the urgency of the situation.

Absolutely.

If it's life -threatening flash pulmonary edema, where the lungs are filling with fluid, you need potent, fast -acting drugs, 4V loop diuretics.

If it's cerebral edema, you need mannitol right now.

And if it's more of a chronic, stable situation?

Then you treat the underlying cause first and foremost.

You use diuretics like psiazides or spironolactone as adjuncts to gently mobilize the fluid and make the patient more comfortable.

There is a specific note in the chapter on managing edema in cirrhosis.

Yes, cirrhosis patients are a special case.

They often have very high aldosterone levels because their failing liver can't metabolize the hormone.

So spironolactone is particularly effective for them, often combined with a loop diuretic to manage the mass of ascites, which is that fluid that builds up in the belly.

Okay, let's wrap this entire deep dive up.

If you're that med student listening, what's in our final toolbox?

Okay, the toolbox summary.

Thiazides, your daily driver for blood pressure and mild edema.

Remember, they save calcium, so think kidney stones.

Watch for low potassium.

Loop diuretics, your heavy artillery for heart failure and renal failure emergencies.

Remember, they lose calcium.

Watch for electrolyte crashes and, of course, the ears.

Potassium sparrers, your balancers, almost always used in combination to offset the potassium loss from the others.

Osmotics and CA inhibitors, your niche specialists.

Think brain, eyes, and altitude sickness.

Aquaretics,

the Vaptans, for when you just need to ditch free water and fix a tricky low sodium.

And the final thought to leave everyone with.

Just a reminder that while we're talking about manipulating all these ion channels and pumps, the goal is never just more pee.

The goal is homeostasis.

We are trying to restore the delicate internal environment of the body to its proper balance.

It's a constant balancing act, and these powerful drugs are the weights we use to try and level the scale.

Beautifully said.

That is Chapter 13 of Brenner and Stevens, unpacked and deep dived.

We really hope this helps you ace that exam or maybe just understand your own prescription a little better.

Thanks for listening to the deep dive.

This has been the Last Minute Lecture Team signing off.

Good luck.